Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Kenichi TAKAYASU"'
Autor:
Shigeo Yasuda, MD, PhD, Hirotoshi Kato, MD, PhD, Hiroshi Imada, MD, PhD, Yuka Isozaki, MD, PhD, Goro Kasuya, MD, PhD, Hirokazu Makishima, MD, PhD, Hiroshi Tsuji, MD, PhD, Daniel K. Ebner, BS, Shigeru Yamada, MD, PhD, Tadashi Kamada, MD, PhD, Hirohiko Tsujii, MD, PhD, Naoya Kato, MD, PhD, Masaru Miyazaki, MD, PhD, Shigeki Arii, Masaaki Ebara, Junji Furuse, Kiyoshi Ohara, Takuji Okusaka, Takehito Otsubo, Masayuki Otsuka, Fumihoko Kanai, Fukuo Kondo, Akiko Saito, Yoshiaki Shimizu, Kenichi Takayasu, Ikuo Udagawa, Hiroshi Yamamoto, Junji Yamamoto, Masakazu Yamamoto, Osamu Yokosuka, Hiroyuki Yoshidome
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 2, Pp 196-203 (2020)
Purpose: Carbon ion beams have several physical and biological advantages compared with conventional radiation for cancer therapy. The objective of this study is to evaluate the safety and effectiveness of 2-fraction carbon ion radiation therapy (CIR
Externí odkaz:
https://doaj.org/article/ab17cbd4745440de837ee7b8a05c953f
Autor:
Iwao, Ikai, Masatoshi, Kudo, Shigeki, Arii, Masao, Omata, Masamichi, Kojiro, Michiie, Sakamoto, Kenichi, Takayasu, Norio, Hayashi, Masatoshi, Makuuchi, Yutaka, Matsuyama, Morito, Monden
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyREFERENCES. 40(11)
In the 18th Nationwide Follow-Up Survey of Primary Liver Cancer in Japan, 20 753 people were newly registered as patients with primary liver cancer at 544 medical institutions over a period of 2 years (from 1 January 2004 to 31 December 2005). Of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e1fb118b933589f6d17d22f335e31a5
https://pubmed.ncbi.nlm.nih.gov/34818831
https://pubmed.ncbi.nlm.nih.gov/34818831
Autor:
Osamu Nakashima, Masumi Kadoya, Shoji Kubo, Yutaka Matsuyama, Michiie Sakamoto, Yonson Ku, Masatoshi Kudo, Takashi Kokudo, Takashi Kumada, Yasuhiro Hagiwara, Namiki Izumi, Tadatoshi Takayama, Shigeki Arii, Norihiro Kokudo, Kenichi Takayasu, Shuichi Kaneko
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 38(3)
Background and aims Small hypovascular hepatocellular carcinoma (HCC) ≤2 cm is biologically less aggressive than hypervascular one, however, the optimal treatment is still undetermined. The efficacy of surgical resection (SR), radiofrequency ablati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9bf7bf3b8eea7a3772c891c1cccd100
https://pubmed.ncbi.nlm.nih.gov/29469211
https://pubmed.ncbi.nlm.nih.gov/29469211
Autor:
Kenichi Takayasu
Publikováno v:
Oncology. 81:105-110
Transcatheter arterial chemoembolization (TACE) is widely performed in 32% of the patients with unresectable hepatocellular carcinoma (HCC) at initial diagnosis and in 58% of those with recurrent HCC in Japan. However, the patient population which un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339faf3965b937412a71f70472e14e40
https://doi.org/10.1159/000333269
https://doi.org/10.1159/000333269
Autor:
Shigeki Arii, Kenichi Takayasu, Masamichi Kojiro, Michiie Sakamoto, Morito Monden, Iwao Ikai, Yutaka Matsuyama, Norio Hayashi, Masao Omata, Masatoshi Makuuchi, Masatoshi Kudo
Publikováno v:
Hepatology Research. 40:1043-1059
In the 18th Nationwide Follow-Up Survey of Primary Liver Cancer in Japan, 20 753 people were newly registered as patients with primary liver cancer at 544 medical institutions over a period of 2 years (from 1 January 2004 to 31 December 2005). Of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f110fd873a5dac134b519b8f4204c8e8
https://doi.org/10.1111/j.1872-034x.2010.00731.x
https://doi.org/10.1111/j.1872-034x.2010.00731.x
Autor:
Shouji Kubo, Masatoshi Makuuchi, Masatoshi Kudo, Iwao Ikai, Junji Furuse, M. Tanaka, Kenichi Takayasu, Michiie Sakamoto, Kenji Nakamura
Publikováno v:
Hepatology Research. 40:686-692
The World Health Organization (WHO) criteria and Response Evaluation Criteria in Solid Tumors (RECIST) are inappropriate to assess the direct effects of treatment on the hepatocellular carcinoma (HCC) by locoreginal therapies such as radiofrequency a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69ec2847af2ebd96acc8425fb98c56a9
https://doi.org/10.1111/j.1872-034x.2010.00674.x
https://doi.org/10.1111/j.1872-034x.2010.00674.x
Autor:
Yutaka Matsuyama, Iwao Ikai, Masatoshi Makuuchi, Kenichi Takayasu, Shigeki Arii, Masamichi Kojiro, Masatoshi Kudo
Publikováno v:
American Journal of Roentgenology. 194:830-837
Although iodized oil transarterial chemoembolization (TACE) has been found to have survival benefit in the care of patients with unresectable hepatocellular carcinoma, iodized oil infusion chemotherapy without embolization has not been clearly found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817f29c1b0815cf7dd84e6d9616e8e41
https://doi.org/10.2214/ajr.09.3308
https://doi.org/10.2214/ajr.09.3308
Autor:
Kenichi Takayasu
Publikováno v:
Oncology. 78:135-141
Of 15,681 patients with hepatocellular carcinoma (HCC), 30% underwent transcatheter arterial chemoembolization with lipiodol (Lip-TACE) including infusion chemotherapy with lipiodol (Lip-TAI) for the initial treatment, and 58% underwent it for recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8842512b62e91a4b3a7bf6c228dea81
https://doi.org/10.1159/000315242
https://doi.org/10.1159/000315242
Autor:
Masatoshi Kudo, M. Tanaka, Masatoshi Makuuchi, Iwao Ikai, Shouji Kubo, Kenichi Takayasu, Michiie Sakamoto, Junji Furuse, Kenji Nakamura
Publikováno v:
Kanzo. 51:261-266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa2b6012f36bfe6ebea700309a5c29b1
https://doi.org/10.2957/kanzo.51.261
https://doi.org/10.2957/kanzo.51.261
Autor:
Kiwamu Okita, Susumu Eguchi, Yasuni Nakanuma, Masamichi Kojiro, Kenichi Takayasu, Takashi Kanematsu, Masao Omata, Yutaka Matsuyama, Morito Monden, Iwao Ikai, Masatoshi Okazaki, Shigeki Arii, Masatoshi Kudo, Masatoshi Makuuchi
Publikováno v:
Surgery. 143:469-475
Although a surgical resection is an important modality for the treatment of hepatocellular carcinoma (HCC), the impact of the operative method on both the patient survival and disease-free survival (DFS) still remains controversial.Using a nationwide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90bfd888d08fff75723a4de7ef665e4d
https://doi.org/10.1016/j.surg.2007.12.003
https://doi.org/10.1016/j.surg.2007.12.003